AGEN US Equity
Agenus IncHealth Care · Biological Products, (No Diagnostic Substances) · CIK 1098972 · FY ends Dec 31$8.26
+0.73 (+9.69%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 6.2M |
| % of shares out | 13.8% |
| Days to cover | 3.0 |
| Δ vs 2026-07-15 | -11.7% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 6,232,820 | -11.7% | 2,045,159 | 3.0 |
| 2026-07-15 | 7,057,525 | +17.7% | 18,443,351 | 1.0 |
| 2026-06-30 | 5,994,778 | +25.5% | 1,105,541 | 5.4 |
| 2026-06-15 | 4,777,994 | -12.6% | 574,784 | 8.3 |
| 2026-05-29 | 5,464,046 | +2.8% | 660,410 | 8.3 |
| 2026-05-15 | 5,316,189 | +21.2% | 874,678 | 6.1 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
